Login
Subscribeclinical trials, funding, NIH
Are the Kids Alright?
Bob Grant | Mar 1, 2012 | 10+ min read
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?